The physiological role of EGFR is to regulate epithelial cell function (Sigismund et al., 2018), and mutated EGFR is aberrantly expressed to trigger cancer, and such mutations are found in more than half of Asian NSCLC patients (Lu et al., 2021). Here, EGFR is linked to non-small cell lung carcinoma.